AUROBINDO PHARMA LTD. - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download 
|
< Back |
| 27 Sep 2023 | |
| Auro Vaccines Private Limited, a wholly owned subsidiary of the Company, has entered into a Licence Agreement with Hilleman Laboratories Singapore Pte. Ltd., to develop, manufacture and commercialise a pentavalent vaccine candidate used in children vaccination. | |
| View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |
Mutual Fund Selector
Find the fund that is right for you© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback